Tag: Viking Therapeutics

This week, Viking Therapeutics' management is engaging directly with institutional investors at two separate events in Miami. The central topic ...

Investor focus returns to Viking Therapeutics next week as company executives prepare to outline their strategic vision at two major ...

The coming year represents a critical juncture for Viking Therapeutics, a biotechnology firm whose clinical pipeline is drawing significant investor ...

Investors in Viking Therapeutics are currently focused on a specific calendar event rather than breaking news. The biopharmaceutical firm is ...

Shares of Viking Therapeutics are trading within a consolidated range as the market anticipates significant corporate news. The biotechnology firm ...

Biopharmaceutical company Viking Therapeutics has moved its lead obesity treatment candidate into the final stage of clinical development, following the ...

While Viking Therapeutics shares continue to navigate a challenging correction, having shed approximately 15% over the past month, a recent ...

Viking Therapeutics has filed a mandatory disclosure with the U.S. Securities and Exchange Commission (SEC) detailing the compensation package for ...

Shares of Viking Therapeutics experienced a significant rally in today's trading session, marking a notable recovery after a volatile period ...

Shares of Viking Therapeutics have posted significant gains, fueled by renewed takeover speculation within the obesity drug sector. This sentiment ...